

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 6.38487479 |
| 2 | nuclear pore organization (GO:0006999) | 5.40942484 |
| 3 | mitotic sister chromatid cohesion (GO:0007064) | 4.91994537 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.80729201 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.80729201 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.80729201 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.80729201 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.80729201 |
| 9 | positive regulation by symbiont of host defense response (GO:0052509) | 4.80729201 |
| 10 | pore complex assembly (GO:0046931) | 4.60893051 |
| 11 | thrombin receptor signaling pathway (GO:0070493) | 4.08605793 |
| 12 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.04555717 |
| 13 | microglial cell activation (GO:0001774) | 3.86082264 |
| 14 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 3.81503384 |
| 15 | protein localization to kinetochore (GO:0034501) | 3.68154693 |
| 16 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.65198460 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 3.58074210 |
| 18 | ribosome assembly (GO:0042255) | 3.52871967 |
| 19 | regulation of histone H3-K9 methylation (GO:0051570) | 3.49405043 |
| 20 | COPII vesicle coating (GO:0048208) | 3.47961196 |
| 21 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.45275771 |
| 22 | protein localization to chromosome, centromeric region (GO:0071459) | 3.39187707 |
| 23 | mitotic metaphase plate congression (GO:0007080) | 3.34200437 |
| 24 | protein neddylation (GO:0045116) | 3.31646993 |
| 25 | DNA synthesis involved in DNA repair (GO:0000731) | 3.31116378 |
| 26 | mesodermal cell differentiation (GO:0048333) | 3.30003528 |
| 27 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.26812692 |
| 28 | response to host immune response (GO:0052572) | 3.26381227 |
| 29 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.26381227 |
| 30 | regulation of germinal center formation (GO:0002634) | 3.25159134 |
| 31 | regulation of centriole replication (GO:0046599) | 3.25075645 |
| 32 | germinal center formation (GO:0002467) | 3.17900462 |
| 33 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.17735888 |
| 34 | histone H3-K4 trimethylation (GO:0080182) | 3.14875583 |
| 35 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.08514058 |
| 36 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.08482275 |
| 37 | negative regulation of fibroblast apoptotic process (GO:2000270) | 3.08145002 |
| 38 | superoxide anion generation (GO:0042554) | 3.06487628 |
| 39 | negative regulation of DNA repair (GO:0045738) | 3.05321783 |
| 40 | regulation of RNA export from nucleus (GO:0046831) | 3.02130043 |
| 41 | response to host defenses (GO:0052200) | 2.97490856 |
| 42 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.97490856 |
| 43 | response to host (GO:0075136) | 2.97490856 |
| 44 | establishment of chromosome localization (GO:0051303) | 2.97228212 |
| 45 | histone H3-K36 demethylation (GO:0070544) | 2.96623506 |
| 46 | negative regulation of histone methylation (GO:0031061) | 2.94949399 |
| 47 | synapsis (GO:0007129) | 2.94248570 |
| 48 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.94233859 |
| 49 | regulation of establishment of cell polarity (GO:2000114) | 2.93123097 |
| 50 | Rap protein signal transduction (GO:0032486) | 2.91819349 |
| 51 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.91156439 |
| 52 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90513911 |
| 53 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.88737903 |
| 54 | B cell homeostasis (GO:0001782) | 2.84181408 |
| 55 | neutrophil activation involved in immune response (GO:0002283) | 2.83217922 |
| 56 | histone H3-K9 demethylation (GO:0033169) | 2.82203521 |
| 57 | vesicle coating (GO:0006901) | 2.81653658 |
| 58 | hippo signaling (GO:0035329) | 2.80366108 |
| 59 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.78860490 |
| 60 | metaphase plate congression (GO:0051310) | 2.77554896 |
| 61 | protein localization to microtubule (GO:0035372) | 2.76915047 |
| 62 | negative regulation of norepinephrine secretion (GO:0010700) | 2.76554478 |
| 63 | interferon-gamma production (GO:0032609) | 2.76448355 |
| 64 | macrophage activation (GO:0042116) | 2.75950830 |
| 65 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.75567336 |
| 66 | clathrin coat assembly (GO:0048268) | 2.75373381 |
| 67 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.73874553 |
| 68 | hypotonic response (GO:0006971) | 2.73623606 |
| 69 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.72315457 |
| 70 | positive regulation of muscle hypertrophy (GO:0014742) | 2.72315457 |
| 71 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.71945345 |
| 72 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.71866534 |
| 73 | regulation of helicase activity (GO:0051095) | 2.71316677 |
| 74 | negative regulation of phosphoprotein phosphatase activity (GO:0032515) | 2.70607511 |
| 75 | platelet aggregation (GO:0070527) | 2.70587037 |
| 76 | T-helper cell differentiation (GO:0042093) | 2.70249019 |
| 77 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.70249019 |
| 78 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.69838339 |
| 79 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 2.68835877 |
| 80 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66799773 |
| 81 | G-protein coupled receptor internalization (GO:0002031) | 2.65820530 |
| 82 | neutrophil activation (GO:0042119) | 2.65691812 |
| 83 | protein prenylation (GO:0018342) | 2.65444335 |
| 84 | prenylation (GO:0097354) | 2.65444335 |
| 85 | myeloid cell activation involved in immune response (GO:0002275) | 2.63246273 |
| 86 | regulation of Rac protein signal transduction (GO:0035020) | 2.62795486 |
| 87 | positive regulation of receptor recycling (GO:0001921) | 2.62752597 |
| 88 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.61491404 |
| 89 | cellular protein complex localization (GO:0034629) | 2.60704610 |
| 90 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.58362202 |
| 91 | negative regulation of mast cell activation (GO:0033004) | 2.58134847 |
| 92 | negative T cell selection (GO:0043383) | 2.57550035 |
| 93 | cellular response to interleukin-15 (GO:0071350) | 2.55075936 |
| 94 | positive regulation of defense response to virus by host (GO:0002230) | 2.55032876 |
| 95 | response to peptidoglycan (GO:0032494) | 2.54340239 |
| 96 | B cell receptor signaling pathway (GO:0050853) | 2.54304134 |
| 97 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.53567987 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53098138 |
| 99 | negative thymic T cell selection (GO:0045060) | 2.52936040 |
| 100 | regulation of platelet aggregation (GO:0090330) | 2.52837795 |
| 101 | phagocytosis, engulfment (GO:0006911) | 2.52012397 |
| 102 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.51842228 |
| 103 | negative regulation of cell killing (GO:0031342) | 2.51842228 |
| 104 | sister chromatid cohesion (GO:0007062) | 2.51251536 |
| 105 | cell adhesion mediated by integrin (GO:0033627) | 2.49058623 |
| 106 | regulation of antigen processing and presentation (GO:0002577) | 2.48693907 |
| 107 | positive T cell selection (GO:0043368) | 2.47387195 |
| 108 | regulation of DNA endoreduplication (GO:0032875) | 2.46657581 |
| 109 | NLS-bearing protein import into nucleus (GO:0006607) | 2.45601149 |
| 110 | regulation of mast cell degranulation (GO:0043304) | 2.44941293 |
| 111 | dendritic cell chemotaxis (GO:0002407) | 2.44523861 |
| 112 | granulocyte activation (GO:0036230) | 2.44031383 |
| 113 | regulation of platelet activation (GO:0010543) | 2.42653115 |
| 114 | positive regulation of interleukin-1 secretion (GO:0050716) | 2.42450418 |
| 115 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.42237260 |
| 116 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.42217919 |
| 117 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.41604828 |
| 118 | regulation of mast cell activation (GO:0033003) | 2.41320293 |
| 119 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.40932067 |
| 120 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.40163379 |
| 121 | positive thymic T cell selection (GO:0045059) | 2.40118851 |
| 122 | protein localization to chromosome (GO:0034502) | 2.39739269 |
| 123 | N-terminal protein amino acid acetylation (GO:0006474) | 2.39663995 |
| 124 | pericardium development (GO:0060039) | 2.39279321 |
| 125 | dendritic cell migration (GO:0036336) | 2.39128840 |
| 126 | regulation of receptor recycling (GO:0001919) | 2.38810915 |
| 127 | detection of molecule of bacterial origin (GO:0032490) | 2.38622687 |
| 128 | peptidyl-lysine trimethylation (GO:0018023) | 2.38529256 |
| 129 | respiratory burst (GO:0045730) | 2.37933255 |
| 130 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.37924733 |
| 131 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.37694081 |
| 132 | beta-amyloid metabolic process (GO:0050435) | 2.37530489 |
| 133 | NIK/NF-kappaB signaling (GO:0038061) | 2.37139348 |
| 134 | regulation of cofactor metabolic process (GO:0051193) | 2.36823419 |
| 135 | regulation of coenzyme metabolic process (GO:0051196) | 2.36823419 |
| 136 | protein localization to cell surface (GO:0034394) | 2.36611296 |
| 137 | tolerance induction (GO:0002507) | 2.36437359 |
| 138 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.36235023 |
| 139 | sister chromatid segregation (GO:0000819) | 2.36162508 |
| 140 | corticosteroid receptor signaling pathway (GO:0031958) | 2.36105782 |
| 141 | T cell migration (GO:0072678) | 2.35811117 |
| 142 | leukocyte aggregation (GO:0070486) | 2.34846329 |
| 143 | mast cell activation (GO:0045576) | 2.34281335 |
| 144 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.33772115 |
| 145 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.33639920 |
| 146 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.33589692 |
| 147 | regulation of response to tumor cell (GO:0002834) | 2.33339974 |
| 148 | positive regulation of response to tumor cell (GO:0002836) | 2.33339974 |
| 149 | positive regulation of immune response to tumor cell (GO:0002839) | 2.33339974 |
| 150 | regulation of immune response to tumor cell (GO:0002837) | 2.33339974 |
| 151 | phospholipid scrambling (GO:0017121) | 2.33200197 |
| 152 | regulation of interleukin-1 beta secretion (GO:0050706) | 2.32972080 |
| 153 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.32454991 |
| 154 | positive regulation of interleukin-12 production (GO:0032735) | 2.32392502 |
| 155 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.32215636 |
| 156 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.32215636 |
| 157 | positive regulation of histone methylation (GO:0031062) | 2.31332678 |
| 158 | positive regulation of mast cell activation (GO:0033005) | 2.31262415 |
| 159 | peptidyl-threonine modification (GO:0018210) | 2.31115679 |
| 160 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.30886803 |
| 161 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.30506643 |
| 162 | positive regulation of B cell proliferation (GO:0030890) | 2.29678577 |
| 163 | Golgi transport vesicle coating (GO:0048200) | 2.28517699 |
| 164 | COPI coating of Golgi vesicle (GO:0048205) | 2.28517699 |
| 165 | positive regulation of interferon-alpha production (GO:0032727) | 2.28427491 |
| 166 | positive regulation of interleukin-17 production (GO:0032740) | 2.28208570 |
| 167 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.27980911 |
| 168 | positive regulation of mast cell degranulation (GO:0043306) | 2.27980911 |
| 169 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.27505958 |
| 170 | response to muramyl dipeptide (GO:0032495) | 2.27489294 |
| 171 | positive regulation of endothelial cell differentiation (GO:0045603) | 2.27325281 |
| 172 | positive regulation of heat generation (GO:0031652) | 2.27137219 |
| 173 | fibroblast migration (GO:0010761) | 2.26866395 |
| 174 | pre-miRNA processing (GO:0031054) | 2.26239548 |
| 175 | myeloid leukocyte activation (GO:0002274) | 2.26211004 |
| 176 | regulation of steroid hormone biosynthetic process (GO:0090030) | 2.26008521 |
| 177 | embryonic process involved in female pregnancy (GO:0060136) | 2.25060890 |
| 178 | establishment of endothelial barrier (GO:0061028) | 2.24362957 |
| 179 | response to interleukin-15 (GO:0070672) | 2.24186377 |
| 180 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.24147823 |
| 181 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.24147823 |
| 182 | T cell differentiation involved in immune response (GO:0002292) | 2.24147823 |
| 183 | platelet formation (GO:0030220) | 2.23921560 |
| 184 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.23656587 |
| 185 | adenosine receptor signaling pathway (GO:0001973) | 2.22503937 |
| 186 | positive regulation of granulocyte differentiation (GO:0030854) | 2.22449263 |
| 187 | nuclear envelope disassembly (GO:0051081) | 2.21898345 |
| 188 | membrane disassembly (GO:0030397) | 2.21898345 |
| 189 | B cell proliferation (GO:0042100) | 2.21809155 |
| 190 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.21657561 |
| 191 | regulation of interferon-alpha production (GO:0032647) | 2.21347991 |
| 192 | regulation of B cell proliferation (GO:0030888) | 2.20787000 |
| 193 | detection of other organism (GO:0098543) | 2.19679309 |
| 194 | regulation of fever generation (GO:0031620) | 2.19273520 |
| 195 | regulation of cell communication by electrical coupling (GO:0010649) | 2.18480085 |
| 196 | leukocyte tethering or rolling (GO:0050901) | 2.18473221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.02702684 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.88692012 |
| 3 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.58052763 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.18595049 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.95058750 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.85907489 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.75265494 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.71293814 |
| 9 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.61531998 |
| 10 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.55668005 |
| 11 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.51096094 |
| 12 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.46775865 |
| 13 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.45694688 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.38744277 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.38362474 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.37066536 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.28599512 |
| 18 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.23572827 |
| 19 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.16972772 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.16402710 |
| 21 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.15015504 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.14015324 |
| 23 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.11314779 |
| 24 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.10839375 |
| 25 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.08537424 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.99091644 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.98460820 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.97708005 |
| 29 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.92291379 |
| 30 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.91881346 |
| 31 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.88525040 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.78561452 |
| 33 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.75556840 |
| 34 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.72156225 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.71637743 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.70223996 |
| 37 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.70066516 |
| 38 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.67761995 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.67269511 |
| 40 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.66805476 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.66322977 |
| 42 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65915939 |
| 43 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64881362 |
| 44 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.63509754 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.60086684 |
| 46 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.55823856 |
| 47 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.55521350 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.55368880 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54750512 |
| 50 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.54314733 |
| 51 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.54314733 |
| 52 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53622758 |
| 53 | P300_19829295_ChIP-Seq_ESCs_Human | 1.53359863 |
| 54 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.48212866 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.48212866 |
| 56 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.47595774 |
| 57 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.46602203 |
| 58 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.46430690 |
| 59 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46197407 |
| 60 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.45520087 |
| 61 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.45301590 |
| 62 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.44948867 |
| 63 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42641321 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.42570394 |
| 65 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.41056469 |
| 66 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.40241791 |
| 67 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.36450468 |
| 68 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.35442668 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.35368990 |
| 70 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.34930516 |
| 71 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.33747203 |
| 72 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.33390562 |
| 73 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.32835481 |
| 74 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32488785 |
| 75 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30631431 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30582429 |
| 77 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29943125 |
| 78 | EWS_26573619_Chip-Seq_HEK293_Human | 1.29942200 |
| 79 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.29559236 |
| 80 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27155879 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.26966909 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26743759 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25439175 |
| 84 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.24749040 |
| 85 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.23979923 |
| 86 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.23334393 |
| 87 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.22394797 |
| 88 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.21872534 |
| 89 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20462512 |
| 90 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.18998226 |
| 91 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.18624404 |
| 92 | TCF4_23295773_ChIP-Seq_U87_Human | 1.17560800 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.16571378 |
| 94 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16230240 |
| 95 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.16106761 |
| 96 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15978677 |
| 97 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.15494101 |
| 98 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.15419420 |
| 99 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.13405209 |
| 100 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13376305 |
| 101 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.13187437 |
| 102 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13025963 |
| 103 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12450364 |
| 104 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.11295683 |
| 105 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.10605148 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10531013 |
| 107 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09692889 |
| 108 | MYB_26560356_Chip-Seq_TH2_Human | 1.09690203 |
| 109 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08940817 |
| 110 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.08918393 |
| 111 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.08627290 |
| 112 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08311648 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08103444 |
| 114 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.06813481 |
| 115 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06774896 |
| 116 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06774896 |
| 117 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.05304719 |
| 118 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04587115 |
| 119 | * RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.04555199 |
| 120 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.04044055 |
| 121 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.03476323 |
| 122 | RXR_22108803_ChIP-Seq_LS180_Human | 1.03215321 |
| 123 | TP53_16413492_ChIP-PET_HCT116_Human | 1.01499270 |
| 124 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.01296719 |
| 125 | * TP63_23658742_ChIP-Seq_EP156T_Human | 1.01035932 |
| 126 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.00429649 |
| 127 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.00330746 |
| 128 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.00040818 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99950953 |
| 130 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.99743395 |
| 131 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.99053770 |
| 132 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.98799326 |
| 133 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.98787675 |
| 134 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.98611153 |
| 135 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98318691 |
| 136 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98318691 |
| 137 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98318691 |
| 138 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97663687 |
| 139 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97601412 |
| 140 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97246571 |
| 141 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.96853218 |
| 142 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96731835 |
| 143 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.95533904 |
| 144 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.95429868 |
| 145 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94278197 |
| 146 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 0.93971304 |
| 147 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93946407 |
| 148 | CJUN_26792858_Chip-Seq_BT549_Human | 0.91502181 |
| 149 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.91450517 |
| 150 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90967127 |
| 151 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.90887116 |
| 152 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.89650240 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 3.98294542 |
| 2 | MP0008004_abnormal_stomach_pH | 3.78877744 |
| 3 | MP0010352_gastrointestinal_tract_polyps | 3.56892740 |
| 4 | MP0003566_abnormal_cell_adhesion | 3.45048942 |
| 5 | MP0005671_abnormal_response_to | 3.24305349 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.17264875 |
| 7 | MP0003787_abnormal_imprinting | 2.87192719 |
| 8 | MP0006054_spinal_hemorrhage | 2.71624705 |
| 9 | MP0002877_abnormal_melanocyte_morpholog | 2.69265640 |
| 10 | MP0009697_abnormal_copulation | 2.49764698 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.45445669 |
| 12 | MP0003890_abnormal_embryonic-extraembry | 2.40727440 |
| 13 | MP0005387_immune_system_phenotype | 2.40576517 |
| 14 | MP0001790_abnormal_immune_system | 2.40576517 |
| 15 | MP0003724_increased_susceptibility_to | 2.33780876 |
| 16 | MP0001800_abnormal_humoral_immune | 2.30219105 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.28176885 |
| 18 | MP0002452_abnormal_antigen_presenting | 2.21562181 |
| 19 | MP0002419_abnormal_innate_immunity | 2.20936997 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.19949692 |
| 21 | MP0005310_abnormal_salivary_gland | 2.19805401 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.17318609 |
| 23 | MP0000015_abnormal_ear_pigmentation | 2.16007332 |
| 24 | MP0001188_hyperpigmentation | 2.14334637 |
| 25 | MP0002277_abnormal_respiratory_mucosa | 2.13817006 |
| 26 | MP0008057_abnormal_DNA_replication | 2.12688690 |
| 27 | MP0002723_abnormal_immune_serum | 2.07161437 |
| 28 | MP0002396_abnormal_hematopoietic_system | 2.03891877 |
| 29 | MP0001819_abnormal_immune_cell | 2.02597017 |
| 30 | MP0002420_abnormal_adaptive_immunity | 2.02321049 |
| 31 | MP0000465_gastrointestinal_hemorrhage | 1.91874515 |
| 32 | MP0010234_abnormal_vibrissa_follicle | 1.91669502 |
| 33 | MP0009785_altered_susceptibility_to | 1.90381023 |
| 34 | MP0004510_myositis | 1.80300365 |
| 35 | MP0005025_abnormal_response_to | 1.79493708 |
| 36 | MP0004272_abnormal_basement_membrane | 1.78548834 |
| 37 | MP0001730_embryonic_growth_arrest | 1.76734911 |
| 38 | MP0008438_abnormal_cutaneous_collagen | 1.73625827 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.72996192 |
| 40 | MP0002009_preneoplasia | 1.71324697 |
| 41 | MP0006082_CNS_inflammation | 1.69276085 |
| 42 | MP0002006_tumorigenesis | 1.69275458 |
| 43 | MP0005275_abnormal_skin_tensile | 1.69166071 |
| 44 | MP0008058_abnormal_DNA_repair | 1.63488987 |
| 45 | MP0001915_intracranial_hemorrhage | 1.61091334 |
| 46 | MP0002398_abnormal_bone_marrow | 1.60982412 |
| 47 | MP0004036_abnormal_muscle_relaxation | 1.60527460 |
| 48 | MP0001986_abnormal_taste_sensitivity | 1.57698662 |
| 49 | MP0010094_abnormal_chromosome_stability | 1.55252115 |
| 50 | MP0005171_absent_coat_pigmentation | 1.53301155 |
| 51 | MP0000716_abnormal_immune_system | 1.52445224 |
| 52 | MP0004484_altered_response_of | 1.52125140 |
| 53 | MP0003111_abnormal_nucleus_morphology | 1.51693530 |
| 54 | MP0003763_abnormal_thymus_physiology | 1.50284521 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.49935412 |
| 56 | MP0003436_decreased_susceptibility_to | 1.47623949 |
| 57 | MP0002405_respiratory_system_inflammati | 1.47241864 |
| 58 | MP0003172_abnormal_lysosome_physiology | 1.47112792 |
| 59 | MP0002735_abnormal_chemical_nociception | 1.46163523 |
| 60 | MP0000685_abnormal_immune_system | 1.46047789 |
| 61 | MP0001851_eye_inflammation | 1.44704379 |
| 62 | MP0004233_abnormal_muscle_weight | 1.43668437 |
| 63 | MP0008260_abnormal_autophagy | 1.42890820 |
| 64 | MP0008932_abnormal_embryonic_tissue | 1.42862801 |
| 65 | MP0005380_embryogenesis_phenotype | 1.41846231 |
| 66 | MP0001672_abnormal_embryogenesis/_devel | 1.41846231 |
| 67 | MP0002086_abnormal_extraembryonic_tissu | 1.41787558 |
| 68 | MP0002084_abnormal_developmental_patter | 1.40708949 |
| 69 | MP0003077_abnormal_cell_cycle | 1.39374360 |
| 70 | MP0005621_abnormal_cell_physiology | 1.38599925 |
| 71 | MP0003303_peritoneal_inflammation | 1.37044812 |
| 72 | MP0008877_abnormal_DNA_methylation | 1.36049284 |
| 73 | MP0003984_embryonic_growth_retardation | 1.35856093 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.35710992 |
| 75 | MP0003045_fibrosis | 1.34115169 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 1.33326900 |
| 77 | MP0001873_stomach_inflammation | 1.33258305 |
| 78 | MP0000383_abnormal_hair_follicle | 1.33073947 |
| 79 | MP0001661_extended_life_span | 1.31302100 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30899954 |
| 81 | MP0002088_abnormal_embryonic_growth/wei | 1.30554087 |
| 82 | MP0003828_pulmonary_edema | 1.30386521 |
| 83 | MP0004808_abnormal_hematopoietic_stem | 1.29632747 |
| 84 | MP0001697_abnormal_embryo_size | 1.28606620 |
| 85 | MP0009333_abnormal_splenocyte_physiolog | 1.20714656 |
| 86 | MP0005174_abnormal_tail_pigmentation | 1.20654742 |
| 87 | MP0008007_abnormal_cellular_replicative | 1.20602654 |
| 88 | MP0005645_abnormal_hypothalamus_physiol | 1.20399160 |
| 89 | MP0005384_cellular_phenotype | 1.18681599 |
| 90 | MP0000579_abnormal_nail_morphology | 1.18090673 |
| 91 | MP0003183_abnormal_peptide_metabolism | 1.17370059 |
| 92 | MP0010155_abnormal_intestine_physiology | 1.17370000 |
| 93 | MP0000689_abnormal_spleen_morphology | 1.16984114 |
| 94 | MP0000350_abnormal_cell_proliferation | 1.16410241 |
| 95 | MP0004147_increased_porphyrin_level | 1.16110771 |
| 96 | MP0001545_abnormal_hematopoietic_system | 1.15298011 |
| 97 | MP0005397_hematopoietic_system_phenotyp | 1.15298011 |
| 98 | MP0009703_decreased_birth_body | 1.14698965 |
| 99 | MP0003453_abnormal_keratinocyte_physiol | 1.13398167 |
| 100 | MP0005023_abnormal_wound_healing | 1.12439997 |
| 101 | MP0003718_maternal_effect | 1.11873739 |
| 102 | MP0002796_impaired_skin_barrier | 1.10357359 |
| 103 | MP0002429_abnormal_blood_cell | 1.09851786 |
| 104 | MP0004215_abnormal_myocardial_fiber | 1.09246093 |
| 105 | MP0000372_irregular_coat_pigmentation | 1.08142514 |
| 106 | MP0001845_abnormal_inflammatory_respons | 1.07487306 |
| 107 | MP0006292_abnormal_olfactory_placode | 1.07373429 |
| 108 | MP0005623_abnormal_meninges_morphology | 1.06822219 |
| 109 | MP0002722_abnormal_immune_system | 1.06641595 |
| 110 | MP0005646_abnormal_pituitary_gland | 1.05661447 |
| 111 | MP0003448_altered_tumor_morphology | 1.00952505 |
| 112 | MP0003091_abnormal_cell_migration | 0.99700800 |
| 113 | MP0002332_abnormal_exercise_endurance | 0.99169781 |
| 114 | MP0002080_prenatal_lethality | 0.99090222 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.97394013 |
| 116 | MP0004270_analgesia | 0.96247356 |
| 117 | MP0002972_abnormal_cardiac_muscle | 0.95865423 |
| 118 | MP0001533_abnormal_skeleton_physiology | 0.95156696 |
| 119 | MP0002998_abnormal_bone_remodeling | 0.94833344 |
| 120 | MP0005501_abnormal_skin_physiology | 0.93849698 |
| 121 | MP0005058_abnormal_lysosome_morphology | 0.93769151 |
| 122 | MP0002163_abnormal_gland_morphology | 0.92704193 |
| 123 | MP0004947_skin_inflammation | 0.92432736 |
| 124 | MP0002933_joint_inflammation | 0.92361069 |
| 125 | MP0000358_abnormal_cell_content/ | 0.89521305 |
| 126 | MP0000703_abnormal_thymus_morphology | 0.89274036 |
| 127 | MP0002060_abnormal_skin_morphology | 0.89041788 |
| 128 | MP0004134_abnormal_chest_morphology | 0.88934745 |
| 129 | MP0005187_abnormal_penis_morphology | 0.88007702 |
| 130 | MP0004087_abnormal_muscle_fiber | 0.87703951 |
| 131 | MP0009764_decreased_sensitivity_to | 0.87004497 |
| 132 | MP0009672_abnormal_birth_weight | 0.86484233 |
| 133 | MP0000428_abnormal_craniofacial_morphol | 0.85176727 |
| 134 | MP0005367_renal/urinary_system_phenotyp | 0.84932902 |
| 135 | MP0000516_abnormal_urinary_system | 0.84932902 |
| 136 | MP0004197_abnormal_fetal_growth/weight/ | 0.84368141 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.82729374 |
| 138 | MP0002736_abnormal_nociception_after | 0.82409693 |
| 139 | MP0005409_darkened_coat_color | 0.80830689 |
| 140 | MP0002085_abnormal_embryonic_tissue | 0.80592015 |
| 141 | MP0002095_abnormal_skin_pigmentation | 0.79638541 |
| 142 | MP0001346_abnormal_lacrimal_gland | 0.79540725 |
| 143 | MP0001905_abnormal_dopamine_level | 0.79452512 |
| 144 | MP0000858_altered_metastatic_potential | 0.79216357 |
| 145 | MP0005076_abnormal_cell_differentiation | 0.78940751 |
| 146 | MP0001191_abnormal_skin_condition | 0.78858966 |
| 147 | MP0002734_abnormal_mechanical_nocicepti | 0.78765736 |
| 148 | MP0003693_abnormal_embryo_hatching | 0.78595021 |
| 149 | MP0002269_muscular_atrophy | 0.77317428 |
| 150 | MP0003950_abnormal_plasma_membrane | 0.76419370 |
| 151 | MP0010307_abnormal_tumor_latency | 0.76401699 |
| 152 | MP0001984_abnormal_olfaction | 0.76164269 |
| 153 | MP0003300_gastrointestinal_ulcer | 0.75949116 |
| 154 | MP0002128_abnormal_blood_circulation | 0.74777161 |
| 155 | MP0001784_abnormal_fluid_regulation | 0.73521332 |
| 156 | MP0010630_abnormal_cardiac_muscle | 0.72260544 |
| 157 | MP0010678_abnormal_skin_adnexa | 0.72184460 |
| 158 | MP0001501_abnormal_sleep_pattern | 0.71769516 |
| 159 | MP0002925_abnormal_cardiovascular_devel | 0.71654714 |
| 160 | MP0005395_other_phenotype | 0.71507912 |
| 161 | MP0002876_abnormal_thyroid_physiology | 0.71106236 |
| 162 | MP0001216_abnormal_epidermal_layer | 0.70388847 |
| 163 | MP0005620_abnormal_muscle_contractility | 0.70360710 |
| 164 | MP0000490_abnormal_crypts_of | 0.69449516 |
| 165 | MP0001968_abnormal_touch/_nociception | 0.69347874 |
| 166 | MP0000767_abnormal_smooth_muscle | 0.69166575 |
| 167 | MP0002928_abnormal_bile_duct | 0.68996354 |
| 168 | MP0002638_abnormal_pupillary_reflex | 0.68637796 |
| 169 | MP0006138_congestive_heart_failure | 0.67232757 |
| 170 | MP0005075_abnormal_melanosome_morpholog | 0.66446231 |
| 171 | MP0001486_abnormal_startle_reflex | 0.66154076 |
| 172 | MP0000266_abnormal_heart_morphology | 0.65633091 |
| 173 | MP0009780_abnormal_chondrocyte_physiolo | 0.65236461 |
| 174 | MP0002822_catalepsy | 0.64757597 |
| 175 | MP0005379_endocrine/exocrine_gland_phen | 0.64108760 |
| 176 | MP0005165_increased_susceptibility_to | 0.63962157 |
| 177 | MP0000313_abnormal_cell_death | 0.63609717 |
| 178 | MP0005390_skeleton_phenotype | 0.60943098 |
| 179 | MP0003866_abnormal_defecation | 0.59394861 |
| 180 | MP0003941_abnormal_skin_development | 0.57123874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased mean platelet volume (HP:0011877) | 6.40559558 |
| 2 | Abnormal platelet volume (HP:0011876) | 5.83921344 |
| 3 | Menorrhagia (HP:0000132) | 5.01095723 |
| 4 | Prostate neoplasm (HP:0100787) | 4.87650844 |
| 5 | Petechiae (HP:0000967) | 4.69037212 |
| 6 | Recurrent abscess formation (HP:0002722) | 4.03118623 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.69047205 |
| 8 | Gingival bleeding (HP:0000225) | 3.63223564 |
| 9 | Eczematoid dermatitis (HP:0000976) | 3.46896979 |
| 10 | Epistaxis (HP:0000421) | 3.24946824 |
| 11 | Febrile seizures (HP:0002373) | 3.13322628 |
| 12 | Chromsome breakage (HP:0040012) | 3.13216562 |
| 13 | Volvulus (HP:0002580) | 3.06333179 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.04652756 |
| 15 | Abnormal hair whorl (HP:0010721) | 3.04446838 |
| 16 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.01907396 |
| 17 | Abnormality of the fingertips (HP:0001211) | 2.93281057 |
| 18 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.92848369 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 2.92848369 |
| 20 | Abnormal platelet function (HP:0011869) | 2.83071087 |
| 21 | Impaired platelet aggregation (HP:0003540) | 2.83071087 |
| 22 | Tetraparesis (HP:0002273) | 2.77085919 |
| 23 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.74529489 |
| 24 | Bladder neoplasm (HP:0009725) | 2.71032583 |
| 25 | Bladder carcinoma (HP:0002862) | 2.71032583 |
| 26 | Deep philtrum (HP:0002002) | 2.68632282 |
| 27 | Abnormal auditory evoked potentials (HP:0006958) | 2.68365015 |
| 28 | Purpura (HP:0000979) | 2.65985723 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 2.65970953 |
| 30 | Optic neuritis (HP:0100653) | 2.65970953 |
| 31 | Spontaneous hematomas (HP:0007420) | 2.65915043 |
| 32 | Abnormality of the prostate (HP:0008775) | 2.65284586 |
| 33 | Papillary thyroid carcinoma (HP:0002895) | 2.64583232 |
| 34 | Vasculitis (HP:0002633) | 2.64215824 |
| 35 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.63379212 |
| 36 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.62792620 |
| 37 | Subaortic stenosis (HP:0001682) | 2.62792620 |
| 38 | Stomach cancer (HP:0012126) | 2.60240108 |
| 39 | Insidious onset (HP:0003587) | 2.59492067 |
| 40 | Termporal pattern (HP:0011008) | 2.59492067 |
| 41 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.59082198 |
| 42 | Biliary tract neoplasm (HP:0100574) | 2.56781360 |
| 43 | Lip pit (HP:0100267) | 2.56590778 |
| 44 | Chronic diarrhea (HP:0002028) | 2.55870611 |
| 45 | Leiomyosarcoma (HP:0100243) | 2.54939602 |
| 46 | Uterine leiomyosarcoma (HP:0002891) | 2.54939602 |
| 47 | Abnormality of the common coagulation pathway (HP:0010990) | 2.54140044 |
| 48 | Dyschromatopsia (HP:0007641) | 2.50569744 |
| 49 | Acanthocytosis (HP:0001927) | 2.49573289 |
| 50 | Shoulder girdle muscle weakness (HP:0003547) | 2.49267497 |
| 51 | Recurrent viral infections (HP:0004429) | 2.48782587 |
| 52 | Thyroiditis (HP:0100646) | 2.48106986 |
| 53 | Recurrent skin infections (HP:0001581) | 2.47221302 |
| 54 | Fair hair (HP:0002286) | 2.47000942 |
| 55 | IgM deficiency (HP:0002850) | 2.43807821 |
| 56 | Ankyloglossia (HP:0010296) | 2.43061249 |
| 57 | Mediastinal lymphadenopathy (HP:0100721) | 2.41679319 |
| 58 | Short middle phalanx of the 5th finger (HP:0004220) | 2.39663044 |
| 59 | Pelvic girdle muscle weakness (HP:0003749) | 2.36219435 |
| 60 | Rhabdomyosarcoma (HP:0002859) | 2.35517193 |
| 61 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.34309119 |
| 62 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.34309119 |
| 63 | Obstructive lung disease (HP:0006536) | 2.34203434 |
| 64 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34203434 |
| 65 | Acute myeloid leukemia (HP:0004808) | 2.33043602 |
| 66 | Stomatitis (HP:0010280) | 2.28099520 |
| 67 | Myositis (HP:0100614) | 2.28008603 |
| 68 | Autoamputation (HP:0001218) | 2.27381489 |
| 69 | Upper limb muscle weakness (HP:0003484) | 2.27070342 |
| 70 | Recurrent pneumonia (HP:0006532) | 2.24943351 |
| 71 | Abnormality of the nasal septum (HP:0000419) | 2.24216027 |
| 72 | Focal motor seizures (HP:0011153) | 2.23531613 |
| 73 | Conjunctival telangiectasia (HP:0000524) | 2.21848721 |
| 74 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.21800166 |
| 75 | Gastrointestinal carcinoma (HP:0002672) | 2.21800166 |
| 76 | Type 2 muscle fiber atrophy (HP:0003554) | 2.21544649 |
| 77 | Pustule (HP:0200039) | 2.21276790 |
| 78 | Cortical dysplasia (HP:0002539) | 2.18912003 |
| 79 | Subacute progressive viral hepatitis (HP:0006572) | 2.16186329 |
| 80 | Generalized hypopigmentation of hair (HP:0011358) | 2.15488589 |
| 81 | Increased IgM level (HP:0003496) | 2.14951523 |
| 82 | Curly hair (HP:0002212) | 2.14644073 |
| 83 | Neoplasm of the small intestine (HP:0100833) | 2.11881376 |
| 84 | Spinal cord lesions (HP:0100561) | 2.11658180 |
| 85 | Syringomyelia (HP:0003396) | 2.11658180 |
| 86 | Hypoplastic labia majora (HP:0000059) | 2.10806162 |
| 87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.10281625 |
| 88 | Osteolytic defects of the hand bones (HP:0009699) | 2.10281625 |
| 89 | Eosinophilia (HP:0001880) | 2.09775581 |
| 90 | Embryonal renal neoplasm (HP:0011794) | 2.09629247 |
| 91 | Fetal akinesia sequence (HP:0001989) | 2.08068109 |
| 92 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.07427292 |
| 93 | Increased density of long bones (HP:0006392) | 2.07292180 |
| 94 | Submucous cleft hard palate (HP:0000176) | 2.05398154 |
| 95 | Abnormality of the labia majora (HP:0012881) | 2.04354351 |
| 96 | Poikilocytosis (HP:0004447) | 2.03232973 |
| 97 | Protruding tongue (HP:0010808) | 2.02425008 |
| 98 | Relative macrocephaly (HP:0004482) | 2.01308229 |
| 99 | Gastrointestinal stroma tumor (HP:0100723) | 2.00930647 |
| 100 | Alveolar cell carcinoma (HP:0006519) | 2.00849461 |
| 101 | Gingivitis (HP:0000230) | 2.00768264 |
| 102 | Anhidrosis (HP:0000970) | 2.00506948 |
| 103 | Inflammation of the large intestine (HP:0002037) | 2.00505387 |
| 104 | Panhypogammaglobulinemia (HP:0003139) | 2.00126287 |
| 105 | Abnormality of T cell number (HP:0011839) | 1.99027452 |
| 106 | Hematochezia (HP:0002573) | 1.97229546 |
| 107 | Granulocytopenia (HP:0001913) | 1.97087241 |
| 108 | Rimmed vacuoles (HP:0003805) | 1.96980476 |
| 109 | Orchitis (HP:0100796) | 1.95971713 |
| 110 | T lymphocytopenia (HP:0005403) | 1.95894490 |
| 111 | Absent frontal sinuses (HP:0002688) | 1.94109657 |
| 112 | Abnormality of chromosome stability (HP:0003220) | 1.93968067 |
| 113 | Agammaglobulinemia (HP:0004432) | 1.93919424 |
| 114 | Abnormality of oral frenula (HP:0000190) | 1.93131362 |
| 115 | Lymphopenia (HP:0001888) | 1.93113605 |
| 116 | Inappropriate behavior (HP:0000719) | 1.92939156 |
| 117 | Leukocytosis (HP:0001974) | 1.92720082 |
| 118 | IgA deficiency (HP:0002720) | 1.90770237 |
| 119 | Neonatal hypoglycemia (HP:0001998) | 1.89697710 |
| 120 | Nemaline bodies (HP:0003798) | 1.88616236 |
| 121 | Large earlobe (HP:0009748) | 1.88408582 |
| 122 | Abnormality of eosinophils (HP:0001879) | 1.88146172 |
| 123 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.88125732 |
| 124 | Thyroid carcinoma (HP:0002890) | 1.87956549 |
| 125 | Colitis (HP:0002583) | 1.87839338 |
| 126 | Long clavicles (HP:0000890) | 1.87727020 |
| 127 | Fatigue (HP:0012378) | 1.87362225 |
| 128 | Atonic seizures (HP:0010819) | 1.87105960 |
| 129 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.86946691 |
| 130 | Muscle fiber atrophy (HP:0100295) | 1.86284304 |
| 131 | Gonadotropin excess (HP:0000837) | 1.86282565 |
| 132 | Fatigable weakness (HP:0003473) | 1.86219123 |
| 133 | Abnormality of the neuromuscular junction (HP:0003398) | 1.86219123 |
| 134 | Neoplasm of the rectum (HP:0100743) | 1.85474993 |
| 135 | Meningitis (HP:0001287) | 1.83832517 |
| 136 | Pulmonary infiltrates (HP:0002113) | 1.83724160 |
| 137 | Autoimmune thrombocytopenia (HP:0001973) | 1.83248061 |
| 138 | Abnormality of B cell number (HP:0010975) | 1.83100230 |
| 139 | B lymphocytopenia (HP:0010976) | 1.83100230 |
| 140 | Aplasia of the musculature (HP:0100854) | 1.82736065 |
| 141 | Medulloblastoma (HP:0002885) | 1.82608480 |
| 142 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.81756859 |
| 143 | Abnormality of the corticospinal tract (HP:0002492) | 1.81137959 |
| 144 | Recurrent lower respiratory tract infections (HP:0002783) | 1.80192252 |
| 145 | Agnosia (HP:0010524) | 1.80045026 |
| 146 | Prolonged bleeding time (HP:0003010) | 1.77409172 |
| 147 | Amaurosis fugax (HP:0100576) | 1.77310513 |
| 148 | Urethral obstruction (HP:0000796) | 1.77305925 |
| 149 | Distal lower limb amyotrophy (HP:0008944) | 1.77022941 |
| 150 | Hypothermia (HP:0002045) | 1.76939567 |
| 151 | Premature rupture of membranes (HP:0001788) | 1.76117223 |
| 152 | Amyotrophic lateral sclerosis (HP:0007354) | 1.76069937 |
| 153 | IgG deficiency (HP:0004315) | 1.75765580 |
| 154 | Weak cry (HP:0001612) | 1.75348130 |
| 155 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.75229313 |
| 156 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.74154453 |
| 157 | Abnormality of macrophages (HP:0004311) | 1.73851438 |
| 158 | Abnormal biliary tract morphology (HP:0012440) | 1.72930613 |
| 159 | Myocardial infarction (HP:0001658) | 1.72787307 |
| 160 | Osteomyelitis (HP:0002754) | 1.72380598 |
| 161 | Bruising susceptibility (HP:0000978) | 1.72363664 |
| 162 | Clubbing of toes (HP:0100760) | 1.72288333 |
| 163 | Uterine neoplasm (HP:0010784) | 1.71644229 |
| 164 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.71468081 |
| 165 | Overgrowth (HP:0001548) | 1.71085356 |
| 166 | Xerostomia (HP:0000217) | 1.71009374 |
| 167 | Spondylolisthesis (HP:0003302) | 1.70613718 |
| 168 | Abnormality of the lower motor neuron (HP:0002366) | 1.70051593 |
| 169 | Cystic hygroma (HP:0000476) | 1.69572537 |
| 170 | Areflexia of lower limbs (HP:0002522) | 1.69098702 |
| 171 | Distal arthrogryposis (HP:0005684) | 1.68126558 |
| 172 | Periodontitis (HP:0000704) | 1.67508995 |
| 173 | Arterial tortuosity (HP:0005116) | 1.66844609 |
| 174 | Distal lower limb muscle weakness (HP:0009053) | 1.66613841 |
| 175 | Abnormality of incisor morphology (HP:0011063) | 1.64891335 |
| 176 | Muscle fiber inclusion bodies (HP:0100299) | 1.64819976 |
| 177 | Restrictive lung disease (HP:0002091) | 1.64391478 |
| 178 | Lower limb amyotrophy (HP:0007210) | 1.63443328 |
| 179 | Ectopic kidney (HP:0000086) | 1.62843164 |
| 180 | Neoplasm of the thyroid gland (HP:0100031) | 1.61471653 |
| 181 | Myelodysplasia (HP:0002863) | 1.60710701 |
| 182 | Oligodactyly (hands) (HP:0001180) | 1.60647794 |
| 183 | Macroorchidism (HP:0000053) | 1.60572116 |
| 184 | Complete atrioventricular canal defect (HP:0001674) | 1.60385849 |
| 185 | Renal cell carcinoma (HP:0005584) | 1.59974992 |
| 186 | Calcaneovalgus deformity (HP:0001848) | 1.59740303 |
| 187 | Atrophic scars (HP:0001075) | 1.59504815 |
| 188 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.59303976 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.86880586 |
| 2 | IRAK3 | 3.16086986 |
| 3 | MAP3K14 | 3.13916278 |
| 4 | ACVR1B | 2.73021760 |
| 5 | TRIM28 | 2.52122124 |
| 6 | RIPK4 | 2.43605420 |
| 7 | PDK2 | 2.41925462 |
| 8 | STK24 | 2.41563425 |
| 9 | IRAK4 | 2.32905903 |
| 10 | TNIK | 2.28954877 |
| 11 | CDK12 | 2.18289836 |
| 12 | JAK3 | 2.10820013 |
| 13 | MAP4K1 | 2.09645989 |
| 14 | BRSK2 | 2.06086681 |
| 15 | EIF2AK1 | 2.05077484 |
| 16 | EIF2AK3 | 1.92483572 |
| 17 | MYLK | 1.91798093 |
| 18 | CASK | 1.88145989 |
| 19 | BMX | 1.87391115 |
| 20 | ZAK | 1.70061726 |
| 21 | TYK2 | 1.69772981 |
| 22 | JAK1 | 1.69368410 |
| 23 | PBK | 1.64872974 |
| 24 | GRK7 | 1.63541572 |
| 25 | NEK6 | 1.60639611 |
| 26 | IKBKE | 1.54299751 |
| 27 | TAOK3 | 1.52519419 |
| 28 | PNCK | 1.52221561 |
| 29 | MET | 1.51970979 |
| 30 | PIK3CG | 1.51918847 |
| 31 | FRK | 1.51486640 |
| 32 | STK38L | 1.50838328 |
| 33 | SGK2 | 1.50789587 |
| 34 | BRD4 | 1.46524621 |
| 35 | ADRBK2 | 1.44637778 |
| 36 | MST4 | 1.44186112 |
| 37 | MST1R | 1.40062985 |
| 38 | TRPM7 | 1.32164060 |
| 39 | IKBKB | 1.29863406 |
| 40 | SCYL2 | 1.27586342 |
| 41 | STK3 | 1.26106888 |
| 42 | KSR1 | 1.25584003 |
| 43 | TTK | 1.25143177 |
| 44 | EIF2AK2 | 1.24863241 |
| 45 | PLK3 | 1.22523019 |
| 46 | PRPF4B | 1.19434510 |
| 47 | CDK3 | 1.19255256 |
| 48 | INSRR | 1.18057918 |
| 49 | TEC | 1.16636370 |
| 50 | TGFBR2 | 1.16255065 |
| 51 | NEK9 | 1.14316195 |
| 52 | HCK | 1.14222161 |
| 53 | GRK5 | 1.13349315 |
| 54 | SRPK1 | 1.11498213 |
| 55 | MARK3 | 1.10998518 |
| 56 | MKNK1 | 1.09117006 |
| 57 | SYK | 1.08946289 |
| 58 | YES1 | 1.07812042 |
| 59 | PLK2 | 1.07229406 |
| 60 | BMPR2 | 1.05946501 |
| 61 | ITK | 1.05512127 |
| 62 | MAP3K2 | 1.03524854 |
| 63 | LCK | 1.03177125 |
| 64 | NEK1 | 0.96795187 |
| 65 | BMPR1B | 0.96357661 |
| 66 | KIT | 0.95231207 |
| 67 | PDGFRB | 0.94296786 |
| 68 | CHUK | 0.94065686 |
| 69 | SGK3 | 0.93994444 |
| 70 | SIK3 | 0.93507159 |
| 71 | MAP3K5 | 0.92882821 |
| 72 | CDK9 | 0.92320677 |
| 73 | FGR | 0.90456283 |
| 74 | CAMK1D | 0.89917240 |
| 75 | TBK1 | 0.89441884 |
| 76 | PTK2B | 0.89093902 |
| 77 | MUSK | 0.88208513 |
| 78 | PDGFRA | 0.87941563 |
| 79 | SGK223 | 0.87933802 |
| 80 | SGK494 | 0.87933802 |
| 81 | RAF1 | 0.87298439 |
| 82 | VRK1 | 0.85096508 |
| 83 | LYN | 0.83910599 |
| 84 | MAP3K13 | 0.83637246 |
| 85 | PAK4 | 0.81408829 |
| 86 | CDK6 | 0.80818473 |
| 87 | FES | 0.79730213 |
| 88 | MKNK2 | 0.79180684 |
| 89 | PIK3CA | 0.76952082 |
| 90 | HIPK2 | 0.76798763 |
| 91 | CSK | 0.75326891 |
| 92 | MAP3K9 | 0.75078592 |
| 93 | CLK1 | 0.73908711 |
| 94 | ZAP70 | 0.73831322 |
| 95 | NUAK1 | 0.73489412 |
| 96 | PKN1 | 0.72152485 |
| 97 | PRKAA2 | 0.71861111 |
| 98 | BTK | 0.71016041 |
| 99 | PRKCQ | 0.70136061 |
| 100 | SGK1 | 0.69987775 |
| 101 | DMPK | 0.69914145 |
| 102 | KSR2 | 0.68982493 |
| 103 | FGFR3 | 0.66761927 |
| 104 | MAPKAPK5 | 0.66596663 |
| 105 | TNK2 | 0.65678066 |
| 106 | MAPK13 | 0.65647178 |
| 107 | OBSCN | 0.64438545 |
| 108 | LATS1 | 0.63676252 |
| 109 | PTK2 | 0.63609228 |
| 110 | NLK | 0.61710636 |
| 111 | CSF1R | 0.61057465 |
| 112 | PIM1 | 0.60779401 |
| 113 | CAMK1G | 0.60312093 |
| 114 | WNK1 | 0.59989101 |
| 115 | BRAF | 0.58370989 |
| 116 | RPS6KA4 | 0.57233736 |
| 117 | LMTK2 | 0.56294570 |
| 118 | TTN | 0.55438675 |
| 119 | FER | 0.55249925 |
| 120 | ILK | 0.54972896 |
| 121 | MAP3K12 | 0.54844970 |
| 122 | MAP3K4 | 0.53433371 |
| 123 | MAPK7 | 0.53309717 |
| 124 | BCR | 0.52950769 |
| 125 | AKT3 | 0.50499848 |
| 126 | STK16 | 0.49675863 |
| 127 | LATS2 | 0.49515486 |
| 128 | PRKCE | 0.49287404 |
| 129 | BLK | 0.49152240 |
| 130 | CHEK1 | 0.49086448 |
| 131 | STK10 | 0.49077347 |
| 132 | MAP2K7 | 0.48666029 |
| 133 | JAK2 | 0.48645003 |
| 134 | NTRK3 | 0.48530665 |
| 135 | STK38 | 0.47837680 |
| 136 | MELK | 0.47708714 |
| 137 | CAMKK2 | 0.47436715 |
| 138 | FGFR1 | 0.46907984 |
| 139 | ATM | 0.46782207 |
| 140 | RET | 0.46516758 |
| 141 | ABL1 | 0.46102235 |
| 142 | ERBB3 | 0.46022379 |
| 143 | ERBB4 | 0.45356036 |
| 144 | MOS | 0.45336549 |
| 145 | CSNK1G1 | 0.45119163 |
| 146 | SIK2 | 0.44308112 |
| 147 | EPHB1 | 0.44197665 |
| 148 | STK4 | 0.44153865 |
| 149 | PLK4 | 0.43232035 |
| 150 | CDC7 | 0.42628686 |
| 151 | MAPK10 | 0.41739021 |
| 152 | STK39 | 0.38248637 |
| 153 | MAP3K6 | 0.37743052 |
| 154 | PAK1 | 0.36858280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.81991821 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 2.39852583 |
| 3 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.02824502 |
| 4 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.02593037 |
| 5 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.94312170 |
| 6 | Cell cycle_Homo sapiens_hsa04110 | 1.93592020 |
| 7 | Thyroid cancer_Homo sapiens_hsa05216 | 1.92873841 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.81800291 |
| 9 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.81132048 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79542004 |
| 11 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.70331296 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 1.64607749 |
| 13 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.63760287 |
| 14 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.63607119 |
| 15 | Focal adhesion_Homo sapiens_hsa04510 | 1.61372187 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.60431403 |
| 17 | Endometrial cancer_Homo sapiens_hsa05213 | 1.56402359 |
| 18 | Measles_Homo sapiens_hsa05162 | 1.55747532 |
| 19 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.55541887 |
| 20 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.47039883 |
| 21 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.46175943 |
| 22 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.45848074 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.43075046 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.42888480 |
| 25 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.41771644 |
| 26 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.41006259 |
| 27 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.37313638 |
| 28 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.36907943 |
| 29 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.35915687 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32890364 |
| 31 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32472330 |
| 32 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28867890 |
| 33 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.28230812 |
| 34 | Colorectal cancer_Homo sapiens_hsa05210 | 1.27462099 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.27454212 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.26027143 |
| 37 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.23673559 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.22020131 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21809152 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.21384752 |
| 41 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21223015 |
| 42 | Asthma_Homo sapiens_hsa05310 | 1.20380185 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.19974976 |
| 44 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18947290 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18356910 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.17533753 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17373956 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.16948581 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.16906149 |
| 50 | Pertussis_Homo sapiens_hsa05133 | 1.12042431 |
| 51 | RNA transport_Homo sapiens_hsa03013 | 1.11350731 |
| 52 | Glioma_Homo sapiens_hsa05214 | 1.10782083 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.10636060 |
| 54 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.10572863 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.10221070 |
| 56 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.08598826 |
| 57 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.07255765 |
| 58 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.06030206 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 1.05011469 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.04230824 |
| 61 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03605250 |
| 62 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.03212471 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 1.03142414 |
| 64 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02697728 |
| 65 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.02169194 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.01904849 |
| 67 | Hepatitis B_Homo sapiens_hsa05161 | 0.99272366 |
| 68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.99232457 |
| 69 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.93911348 |
| 70 | Melanoma_Homo sapiens_hsa05218 | 0.92276227 |
| 71 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90531847 |
| 72 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.90028962 |
| 73 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87392595 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 0.87036086 |
| 75 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86204723 |
| 76 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86151007 |
| 77 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86073027 |
| 78 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.85783991 |
| 79 | Tight junction_Homo sapiens_hsa04530 | 0.85555949 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.85124667 |
| 81 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.84761593 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.84755443 |
| 83 | Viral myocarditis_Homo sapiens_hsa05416 | 0.82526106 |
| 84 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.82106058 |
| 85 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.81994674 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.81952248 |
| 87 | Platelet activation_Homo sapiens_hsa04611 | 0.80788683 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.80310718 |
| 89 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77457585 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77282959 |
| 91 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76940144 |
| 92 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.75706439 |
| 93 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75699082 |
| 94 | Shigellosis_Homo sapiens_hsa05131 | 0.75532075 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.75093505 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.74523786 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.74440689 |
| 98 | Legionellosis_Homo sapiens_hsa05134 | 0.74049628 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.74030140 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73329179 |
| 101 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.73198653 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72790585 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72781131 |
| 104 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72778108 |
| 105 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72562953 |
| 106 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.72066987 |
| 107 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.71563222 |
| 108 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71055876 |
| 109 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.70902286 |
| 110 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70009630 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69416056 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | 0.68439784 |
| 113 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.67213527 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66680069 |
| 115 | Long-term depression_Homo sapiens_hsa04730 | 0.66632854 |
| 116 | Apoptosis_Homo sapiens_hsa04210 | 0.66092104 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65805115 |
| 118 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.65272773 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65001319 |
| 120 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.64709019 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.64166141 |
| 122 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.64033003 |
| 123 | Nicotine addiction_Homo sapiens_hsa05033 | 0.63626675 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.62133024 |
| 125 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.61680343 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61432867 |
| 127 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.61243010 |
| 128 | Circadian entrainment_Homo sapiens_hsa04713 | 0.61242804 |
| 129 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61161842 |
| 130 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.60998315 |
| 131 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.60923816 |
| 132 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.59874141 |
| 133 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59159095 |
| 134 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58914618 |
| 135 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58641359 |
| 136 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58556413 |
| 137 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.58462594 |
| 138 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58351976 |
| 139 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58152807 |
| 140 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57905423 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57807017 |
| 142 | Prostate cancer_Homo sapiens_hsa05215 | 0.57716352 |
| 143 | Adherens junction_Homo sapiens_hsa04520 | 0.57231631 |
| 144 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56958189 |
| 145 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56304874 |
| 146 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.56234457 |
| 147 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.56208632 |
| 148 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.56171307 |
| 149 | Lysosome_Homo sapiens_hsa04142 | 0.56090670 |
| 150 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55356722 |
| 151 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.54983947 |
| 152 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.54600304 |
| 153 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53760171 |
| 154 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53739186 |
| 155 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.53692668 |
| 156 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51924605 |
| 157 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.49981707 |
| 158 | Endocytosis_Homo sapiens_hsa04144 | 0.49920229 |
| 159 | Other glycan degradation_Homo sapiens_hsa00511 | 0.49864468 |
| 160 | Bladder cancer_Homo sapiens_hsa05219 | 0.47156104 |
| 161 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.46296976 |

